Pharmaceutical Technology Europe- February 2022

Pharmaceutical Technology Europe February 2022

Issue link: https://www.e-digitaleditions.com/i/1450659

Contents of this Issue

Navigation

Page 20 of 36

mAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceuticals. CREATING STRONG VALUE IN BIOPHARMACEUTICALS mabxience.com @mAbxience linkedin.com/company/mabxience • Reliable, world-class biological Contract Development and Manufacturing Organization (CDMO). • End to end solutions, latest state-of-the-art technology across multi product API and fill finish facilities. • Committed to global quality standards to manufacture & supply our biosimilars worldwide.

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology Europe- February 2022 - Pharmaceutical Technology Europe February 2022